Navigation Links
Strategy discovered to activate genes that suppress tumors and inhibit cancer
Date:5/21/2012

A team of scientists has developed a promising new strategy for "reactivating" genes that cause cancer tumors to shrink and die. The researchers hope that their discovery will aid in the development of an innovative anti-cancer drug that effectively targets unhealthy, cancerous tissue without damaging healthy, non-cancerous tissue and vital organs. The research will be published in the Journal of Biological Chemistry.

The team, led by Yanming Wang, a Penn State University associate professor of biochemistry and molecular biology, and Gong Chen, a Penn State assistant professor of chemistry, developed the new strategy after years of earlier research on a gene called PAD4 (peptidylarginine deiminase 4), which produces the PAD4 enzyme. Previous research by Wang and other scientists revealed that the PAD4 enzyme plays an important role in protecting the body from infection. The scientists compared normal mice with a functioning PAD4 gene to other mice that had a defective a PAD4 gene. When infected with bacteria, cells from the normal mice attacked and killed about 30 percent of the harmful bacteria, while cells from the defective mice battled a mere 10 percent. The researchers discovered that cells with a functioning PAD4 enzyme are able to build around themselves a protective, bacteria-killing web that Wang and his colleagues dubbed a NET (neutrophil extracellular trap). This NET is especially effective at fighting off flesh-eating bacteria.

Now, in their new study, Wang and his collaborators have focused on the less-desirable effects of the same PAD4 gene. While PAD4 is clearly a critical part of the body's defense strategy, the gene's over-expression may be linked to autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. One situation in which the PAD4 enzyme is markedly increased is in patients with certain cancers, such as breast, lung, and bone cancers. "We know that the PAD4 gene acts to silence tumor-suppres
'/>"/>

Contact: Barbara Kennedy
science@psu.edu
814-863-4682
Penn State
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Governor Rendell Proposes Budget With No Tax Increase, More Money for Public Schools, Strategy for Jobs, Plan to Address Future Deficits
2. SOKO Fitness & Spa Group Broadens Geographic Expansion Strategy
3. Keenan Chief Strategy Officer Selected to Join Editorial Board of Payers & Providers
4. Data Strategy Announces SurePath Services Offering for EMC Avamar
5. New strategy produces promising advance in cancer vaccines
6. New Cancer-Fighting Strategy Focuses On Signaling Molecules
7. Targeting leukemia cells gene addiction presents new strategy for treatment
8. Novel Parkinson's Treatment Strategy Involves Cell Transplantation
9. A new strategy normalizes blood sugars in diabetes
10. Promising strategy for treatment of lung cancer
11. ActiveStrategy iRound™ is Launched to Enable Seamless Capture of Field-Level Performance Management Data
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Strategy discovered to activate genes that suppress tumors and inhibit cancer
(Date:3/2/2015)... 2015 Gummy smile reduction expert, ... reshaping can involve one or several procedures to reduce the ... tissue for a more even gum line. Dr. Farnoosh is ... that can permanently lighten discolored or naturally dark gums. ... involves a personalized treatment plan to address a patient’s specific ...
(Date:3/2/2015)... Burns Engineering's Lab-to-Lab Calibration Service offers ... Platinum Resistance Thermometers (SSPRTs) and industrial Resistance Temperature ... . . . guaranteed. Their metrology ... 200706-0), ISO 9001 and 17025 Certified and provides ... to 500°C, both ITS-90 and Callendar-van Dusen calibrations ...
(Date:3/2/2015)... Over the last five years the ultrasound ... to expand their geographic presence and achieve economies of ... $6.2 billion by 2019 at CAGR of 5.1% from ... and Canada and a major part of Europe are ... as Asia-Pacific including China and India, Latin America and ...
(Date:3/2/2015)... This year, the National Multiple Sclerosis Society’s annual awareness ... people across the country to unite, raise awareness, ... their best lives. MS Awareness Week is a special week ... the Society’s vision of a world free of MS. ... the central nervous system, interrupts the flow of information within ...
(Date:3/2/2015)... 02, 2015 Atlantic Information Services, Inc. ... AIS’s Directory of Health Plans: 2015 , the all-new ... the U.S. health plan market, with enrollment data and ... States. , Available as a printed book containing ... trends in quick-view tables and charts, as well as ...
Breaking Medicine News(10 mins):Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2
... 21 Secretary of Veterans,Affairs Dr. James B. Peake ... panels that will make recommendations on ways the Department,of ... prevention,suicide research and suicide education., "There is nothing ... one of,the great men or women who have served ...
... 1 Day ASV Single Vision Lens Now Available Through Licensed Eye Care ... ... Inc. (OTC,Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops,licenses, manufactures, distributes ... C-VUE(R) 1 Day ASV, which is the,first aspheric, daily disposable contact lens ...
... Leading Pennsylvania Health Insurer Reduce ... DST Health Solutions,today announced an extension of ... health insurer serving nearly 3.4 million,members, for business ... center in Harrisburg, Pa. will,continue to provide business ...
... the Most Promising ... Driving the Future of Technology, SUNNYVALE, Calif., May ... technology in enterprise mobility,today announced that it has won ... most innovative private technology companies based in North,America., ...
... young flight attendant,complains of swelling and tightness in ... her from exercising. Will the ultrasound results indicate,deep ... symptomatology and the frequent presence of comorbidities,make it ... primary care,practice. The Journal of Family Practice has ...
... Thoracic Societys 2008 International Conference in Toronto on Wednesday, May ... young adults. One links low levels of a protein called ... in young women. A second finds that high levels of ... , The data from both studies comes from the ...
Cached Medicine News:Health News:VA Secretary Appoints Panel of National Suicide Experts 2Health News:Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens 2Health News:DST Health Solutions and Independence Blue Cross Extend Business Process Outsourcing Agreement 2Health News:DST Health Solutions and Independence Blue Cross Extend Business Process Outsourcing Agreement 3Health News:Agito Networks Wins Red Herring North America 100 Award Out of More Than 800 Companies 2Health News:Agito Networks Wins Red Herring North America 100 Award Out of More Than 800 Companies 3Health News:CME Publication Gives Clinicians a Leg Up in Treating Disorders of the Lower Extremities 2Health News:Studies provide insights into lung disease and lung function in young adults 2Health News:Studies provide insights into lung disease and lung function in young adults 3
(Date:3/2/2015)... 2, 2015   Emerson Ecologics, LLC ... supplements, prescription products and natural health and ... with Anabolic Laboratories, a leading manufacturer of ... new partnership will allow Anabolic Laboratories to ... practitioner segments and provide customers with added ...
(Date:3/2/2015)... BUENA, N.J., March 2, 2015  IGI Laboratories, Inc. (NYSE ... announced its financial results for the fourth quarter and year ... to Date 2014 Highlights , Total revenues of ... of 104% over the same quarter in 2013 , ... 31, 2014, an increase of 85% over the same period ...
(Date:3/2/2015)... March 2, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... and full year ended December 31, 2014. Financial highlights for ... net loss of $5.3 million, or $0.04 per share. This ... of $22.0 million, or $0.19 per share, for the fourth ... include revenues of $75.3 million and a net loss of ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 2IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 3IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 4IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 5IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 6IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 7IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 8IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 9IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 10IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 11IGI Laboratories Announces Fourth Quarter And Year End 2014 Results 12Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 2Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 3Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 4Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 5Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 6Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 7Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 8Halozyme Reports Fourth Quarter And Full Year 2014 Financial Results 9
... Mass., Aug. 26 Sermo ... physicians, today announced a free Sermo Report titled, " ... covers physician opinions about the introduction of an investigational ... to the results, 46% of physicians feel that ticagrelor ...
... Cardioxyl Pharmaceuticals, Inc. , a clinical-stage pharmaceutical ... disease, today announced that it has initiated a dose-defining ... for the treatment of patients with acute decompensated heart ... at the time of discharge from U.S. hospitals and ...
Cached Medicine Technology:Sermo Report Indicates that Ticagrelor is Likely to Affect the Standard of Care for ACS Patients 2Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 2Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 3Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: